The analgesic medicine sales in Denmark peaked in 2016 at 1060.0 million Danish Krones, experiencing high growth rates especially from 2014 to 2016. From 2017 onward, the market displayed a declining trend with minor fluctuations. The year-on-year variation highlights significant drops in 2019 and 2022 by 16.83% and 10.5% respectively. In 2023, the sales stood at 850.4 million Danish Krones, showing a slight decrease with a CAGR of -3.68% over the past five years. Forecasted data from 2024 to 2028 suggests a steady decline at an average annual rate of -1.26%, projecting a continued reduction in sales.
Future trends to watch for include the influence of new medical regulations, shifts in consumer preferences towards alternative pain management solutions, and potential innovations in pharmaceutical formulations. Monitoring these factors could provide insights into potential market stability or further decline.
